.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Novartis
QuintilesIMS
UBS
Cantor Fitzgerald
Accenture
Cipla
McKinsey
Express Scripts
Dow

Generated: December 15, 2017

DrugPatentWatch Database Preview

FLUOXETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Fluoxetine Hydrochloride patents expire, and what generic alternatives are available?

Fluoxetine Hydrochloride is a drug marketed by Barr, Dr Reddys Labs Ltd, Alembic Pharms Ltd, Ani Pharms Inc, Aurobindo Pharma, Carlsbad, Cr Double Crane, Heritage Pharms Inc, Ivax Sub Teva Pharms, Landela Pharm, Mallinckrodt, Mylan, Mylan Pharms Inc, Par Pharm, Sandoz, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva, Teva Pharms Usa, Wockhardt Ltd, Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Hi Tech Pharma, Lannett, Pharm Assoc, Silarx, Wockhardt, Alvogen, Dr Reddys Labs Inc, Par Form, Par Pharm Inc, and Torrent Pharms Ltd. and is included in forty-seven NDAs.

The generic ingredient in FLUOXETINE HYDROCHLORIDE is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Seventy-two suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
Drug patent expirations by year for FLUOXETINE HYDROCHLORIDE

Pharmacology for FLUOXETINE HYDROCHLORIDE

Medical Subject Heading (MeSH) Categories for FLUOXETINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AlvogenFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideTABLET;ORAL202133-001Oct 6, 2011ABRXYesYes► Subscribe► Subscribe► Subscribe
SandozFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL075049-001Aug 2, 2001AB1RXNoNo► Subscribe► Subscribe► Subscribe
MylanFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL078045-001Nov 17, 2008RXNoNo► Subscribe► Subscribe► Subscribe
Sciegen Pharms IncFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL204597-002Mar 16, 2015AB1RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid AtlanticFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideSOLUTION;ORAL075690-001Jan 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
SandozFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL075807-002Jan 29, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Sciegen Pharms IncFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL204597-003Mar 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms UsaFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL076001-001Jan 29, 2002AB1RXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideSOLUTION;ORAL075292-001Feb 7, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Landela PharmFLUOXETINE HYDROCHLORIDEfluoxetine hydrochlorideCAPSULE;ORAL075464-002Jan 30, 2002AB1RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Farmers Insurance
Medtronic
US Army
QuintilesIMS
Covington
UBS
Argus Health
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot